The U.S. is increasingly dependent on China for critical pharmaceuticals, with China supplying 39.9% of U.S. imports of active pharmaceutical ingredients (APIs) in 2024. This dependency poses a national security risk, as…
Unlimited cluster & entity views, full AI analysis, threat scoring, entities, sources and timelines — free, no card required.
Sign up freeAlready have an account? Log in